China to strengthen adverse events surveillance and response:
This article was originally published in Clinica
China is to strengthen its surveillance of adverse events caused by medical devices. The announcement from the State Food and Drug Administration (SFDA) states that a faster and more effective response to adverse incidents is needed in order to ensure that devices on the market are safe. Methods to achieve a faster and more effective response will be developed, including intervention and removal of products that are a safety risk.